Conclusion: These results their target genes in gastric cancer, which provide important clues for understanding the key roles of lncRNA-miRNA functional network in cancer.
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StepOne Plus (Applied Biosystems, Foster City, CA) was used to perform the ampli ication reaction. And the date was analyzed by the 2 -Ct method. The sequences of primers were also listed in Table 1 .
Western blot analysis
Proteins were extracted from cells with RIPA lysis buffer (KenGEN, China) and were quanti ied using a BCA Protein Assay Kit (Thermo, USA). We add the 30mg of protein lysates to SDS-PAGE. The electrophoresed proteins were transferred to PVDF membranes (Millipore, USA). The membrane was blocked in 5% nonfat milk and incubated with diluted antibodies against ZEB1 (1:1000; CST; USA), Igf1r (1:1000; CST; USA) and Igf2 (1:1000; CST; USA), followed by incubation with a horseradish peroxidase-conjugated secondary antibody (1:5000; Santa Cruz; USA). -actin was used as a control (1:1000, CST, USA).
Dual luciferase reporter assay
The fragment from H19 containing the predicted hsa-miR-141 binding site were chemically synthesized and cloned into the Xhol and Notl sites of the pGL3 vector, respectively. The resulted vectors were called the reporter vector H19-wild type (WT). The corresponding mutants were created by mutating the hsa-miR-141 seed region binding site, which were called the reporter vector H19-mutated-type (MUT).
Hsa-miR-141 mimic or negative control mimic was co-transfected with the reporter vectors containing either the targeting sequences or the corresponding mutants using Transfection reagent (Invitrogen) according to the protocol. Luciferase activity was assayed 48 h after transfection, using a dual luciferase reporter assay system (Promega).
Statistical analysis
The expression differences between GC and matched normal tissues were analyzed using paired samples t-test. Pearson's coef icient correlation was used for expression correlation assay. MTT assays were analyzed using ANOVA. The statistical analyses were performed using SPSS (Version 17.0). P values were two-sided and a value of 0.05 was considered to be statistically signi icant.
Results

Inverse expression of H19 and miR-141 in GC cells and tissues
Real-time PCR revealed that compared with normal tissues, tumors exhibited a signi icantly lower miR-141 expression (Fig. 1A ) and a signi icantly higher H19 expression (Fig. 1B) . Pearson expression analysis suggested that an inverse relationship between miR-141 and H19 expression in tumors (Fig. 1C , r=-0.969, p=0.000). In vitro, miR-141 was signi icantly lower expressed in SGC-7901 and MKN45 compared with non-malignant GES-1 cells (Fig. 1D) , while H19 was signi icantly higher expressed (Fig. 1E) .
Cisplatin (DDP) is a kind of chemotherapy drugs and has been reported to inhibit NFkB and Akt signaling pathways to induce cell apoptosis and inhibit cell proliferation. To investigate the effects of cisplatin on H19 and miR-141, we treated SGC-7901 and MKN45 cells with 10 ug/ml cisplatin for 48 hours. Cisplatin treatment decreased H19 expression and increased miR-141 expression (Fig. 1F-I ), indicating that it had opposing effects on their expression. We also examined other miRNAs which frequently dysregulated in GC. The results showed that miR-223 and miR-101 was signi icantly changed upon cisplatin treatment. However, no correlation was found between miR-223 or miR-101 with H19 (data not shown).
Antagonistic effect of H19 and miR-141 on cell proliferation and invasion
To study the effect of H19 on the proliferation and invasion of GC cells, we transiently transfected 7901 cells with H19 siRNA or control. Transfection of H19 siRNA decreased H19 levels in GC cells ( Fig. 2A) . MTT assays showed that H19 siRNA inhibited proliferation of 7901 and MKN45 cells by about 50% at 96 h (Fig. 2B) . These results indicated that H19 strongly promotes cell proliferation. We also transiently transfected these cells with negative control or miR-141 mimics and studied the effect of miR-141 on the growth of 7901 and MKN45 (Fig. 2C) . These results indicated that miR-141 signi icantly inhibits cell proliferation. Since knock-down of H19 suppressed cell proliferation, we performed apoptosis assays using low cytometry with Annexin-V. We found that H19 siRNA increased apoptosis to about 2 times that of controls in 7901 and MKN45 cells (Fig. 2D) , demonstrating that H19 reduces apoptosis in these cells. We also performed apoptosis assays with miR-141 mimics/inhibitor transfected cells and observed that miR-141 mimics increased cell apoptosis while miR-141 inhibitor reduces apoptosis compared with controls ( Fig. 2E) , demonstrating that miR-141 promotes apoptosis in cancer cells.
Next, we performed transwell invasion assay using Matrigel to investigate the effect of transiently-transfected H19 siRNA on the invasive ability of 7901 and MKN45 cells. The results clearly revealed that H19 siRNA decreased cell invasion to about 30% in cells 
MiR-141 binds to and suppresses H19 expression
We examined the seed sequence of miR-141 in H19 and found a predicted binding site for miR-141 (Fig. 4A) . We cloned the putative miR-141 target binding sequence into a luciferase construct. Luciferase reporter assays with miR-141 overexpressing cells showed that miR-141 repressed luciferase activity (Fig. 4B) . Mutation of the putative miR-141 target sites decreased the response to miR-141, indicating that miR-141 binds to H19 in a sequence speci ic manner. 
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MiR-141 regulates H19 target genes H19 has been reported to induce miR-675 and to repress Igf1r and Igf2 expression. We examined mRNA and protein expression levels after transfection of H19 siRNA or miR-141 to examine whether miR-141 regulates H19 target genes. We found that H19 siRNA and miR-141 reduced miR-675 expression and induced Igf1r and Igf2 expression signi icantly, including mRNA and protein expression (Fig. 5) .
MiR-141 inhibitor restores H19 siRNA function
To examine if the effects of miR-141 on cell proliferation is mediated by H19, we cotransfected cells with H19 siRNA and miR-141 inhibitor. MiR-141 inhibitor transfection decreased miR-141 expression and H19 siRNA transfection decreased H19 expression. Cotransfection of miR-141 inhibitor and H19 siRNA showed that miR-141 inhibitor increased H19 expression repressed by H19 siRNA signi icantly (Fig. 6A and B) .
We also examined miR-675, Igf1r and Igf2 expression which are regulated by H19 after co-transfection of H19 siRNA and miR-141 inhibitor in 7901 cells. MiR-141 inhibitor induced and H19 siRNA reduced miR-675. Co-transfection of miR-141 inhibitor and H19 
MiR-141 suppresses H19 function
We co-transfected cells with H19 expression plasmid and miR-141 and investigated whether miR-141 suppresses the ectopic H19 expression and function. MiR-141 transfection increased miR-141 expression and H19 transfection increased H19 expression. MiR-141 signi icantly decreased the ectopic H19 expression (Fig. 7A and B) .
We also examined miR-675, Igf1r and Igf2 expression which are regulated by H19 after co-transfection of miR-141 and H19 in 7901 cells. MiR-141 reduced and H19 induced miR-675 expression (Fig. 7C) . Co-transfection of miR-141 and H19 showed that miR-141 inhibited the up-regulation of miR-675 by H19. Inversely, miR-141 induced and H19 reduced Igf1r and Igf2. Co-transfection of miR-141 and H19 showed that miR-141 restored the suppression of Igf1r and Igf2 by H19 (Fig. 7D and E) . These results also indicate that miR-141 regulated H19 targeted genes expression.
H19 regulates RNA processing enzyme and miRNA target H19 has a broad effect on miR maturation through interaction with RNA processing enzymes such as DROSHA and DICER. We found that H19 over-expression could signi icantly up-regulate DICER and DROSHA expression, while H19 knockdown down-regulate their Fig. 8A and B) . MiR-141 has been reported to target and repress ZEB1. We examined ZEB1 mRNA and protein expression levels after transfection of H19 siRNA or miR-141 and found that H19 siRNA and miR-141 reduced ZEB1 expression in 7901 cells (Fig.  8C, D and E) . We also co-transfected cells with miR-141 and H19 expression plasmid and investigated whether miR-141 suppresses ZEB1 induced by H19. We found that miR-141 over-expression decreased ZEB1 while H19 overexpression induced ZEB1 (Fig. 8F) . Cotransfection of miR-141 and a H19 expression plasmid showed that miR-141 suppressed ZEB1 induced by H19, suggesting that H19 regulates the miR-141 target gene ZEB1.
Discussion
NcRNAs, with limited protein-coding capacity, are often expressed in a disease-, tissue-or developmental stage-speci ic manner, indicating speci ic functions for lncRNAs in development and diseases and making these molecules attractive therapeutic targets. A growing number of recent papers have revealed that ncRNAs could compete with MREs of mRNA and thus affect gene targets expression [15] . However, the exact role of miRNA and lncRNA interactions in the tumorigenesis of GC remains largely unknown. Understanding the interaction between miRNA and lncRNA would facilitate the development of miRNA/lncRNA based diagnostics and therapeutics against cancers. In this present study, we demonstrated that miR-141 expression was down-regulated in GC tissues while H19 expression was upregulated. Pearson analysis showed that a signi icant inverse correlation between H19 and miR-141. Besides, we also showed for the irst time that up-regualting of miR-141 exerted tumor-suppressive functions in human GC by knockdown of H19 and vice versa.
MiRNAs were found to be dysregulated in several human cancers including GC [16] [17] [18] . Han reported that miR-29c acts as a tumor suppressor in GC by directly targeting ITGB1 [16] . Loss of miR-29c expression is an early event in the initiation of gastric carcinogenesis and may serve as a diagnostic and therapeutic biomarker for patients with GC. H. pylori CagA induces aberrant epigenetic silencing of let-7 expression, leading to Ras upregulation, and thus lead to GC [17] . Our previous study showed that miR-141 acted as a tumor suppressor in human GC by targeting signal transducer and activator of transcription 4 (STAT4) [19] . Mei et al [20] showed that miR-141 expression was signi icantly up-regulated in NSCLC tissues, and its overexpression accelerated NSCLC cell proliferation in vitro and tumor growth in vivo by targeting PHLPP1 and PHLPP2. The reason for this might be that certain genes may be oncogenic in one cell or tissue type but tumor suppressive in another, depending on the cancer type and cellular context. H19 is transcribed in an untranslated RNA molecule that lacks conserved open reading frames but does have a conserved secondary RNA structure which accumulates in the human placenta and several fetal tissues, and probably plays a pivotal role in embryogenesis and fetal growth and tumor development [21] . Emerging evidences have shown that H19 was overexpressed in many types of cancer including hepatocellular [22] , bladder [23] , colon [24] , and breast cancer [25] ; however, the underlying role and mechanism of H19 involved in GC remains unclear. Recently, H19 was reported to act as a sponge to antagonize miRNAs, for example, let-7. Kallen et al [26] found that H19 harbors both canonical and noncanonical binding sites for the let-7 family of microRNAs, which plays important roles in development, cancer, and metabolism. Shi et al [27] suggested that lncRNA H19 and its derivate miR-675 were positively correlated with glioma grade, and H19 regulated glioma cell invasion by deriving miR-675.
In the present study, we investigated both roles of miR-141 and H19 in GC. First, we tested the expression of miR-141 and H19 in GC tissues and cells. We also identi ied the functions of miR-141 and H19 in gastric carcinoma cells by applying gain and loss-offunction approaches. The results demonstrated that H19 was up-regulated in GC tissues and cells while miR-141 was down-regulated. H19 up-regulation and miR-141 downregulation correlated with proliferation, migration and invasion of GC cells. Additionally, H19 suppression and miR-141 overexpression led to the promotion of gastric cell apoptosis. 
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These indings suggested that H19 and miR-141 played a direct role in the modulation of multiple oncogenic properties and GC progression, stimulating new research directions and therapeutic options considering H19 and miR-141 as novel markers in GC. Inspired by the 'competitive endogenous RNAs' regulatory network and emerging evidence that suggests that ncRNAs may participate in this regulatory circuitry, we hypothesized that H19 and miR-141 may also serve as ceRNAs in GC. In support of this notion, we employed bioinformatics analysis and luciferase assays to validate the direct binding ability of miR-141 and H19. As expected, we discovered miR-141 could form complementary base pairing with H19 and induce translational repression of a RLuc-H19 reporter gene. Taken together, these data are consistent with our hypothesis and indicate that H19 may interact with miR-141 to link miR-141 and the post-transcriptional network in gastric pathogenesis.
Next, we examined the role of miR-141 mimic or inhibitor on H19 expression level and H19 targets. We focused on the target genes Igf1r and Igf2 as they are were previously reported to be repressed by H19. After we transfecting with miR-141 mimic, the target genes were signi icantly up-regulated as H19 was inhibited by miR-141 overexpression and thus H19 could not repress Igf1r and Igf2 expression. On the contrary, when cells tranfected with miR-141 inhibitor, the target genes were signi icantly down-regulated and H19 was overexpressed. Besides, we also examined the role of H19 on miR-141 and its target gene ZEB1 level. The results were similar, which showed that H19 could compete with miRNA and affect ZEB1 expression.
However, in the present study, we only investigated one pair of miRNA and lncRNA. The ceRNA activity of H19 may sequester a handful of miRNAs at once, while one miRNA is also capable of controlling multiple genes. We also hypothesize that there may be many other lncRNAs or miRNAs that function as ceRNAs to regulate expression of key genes in GC. Thus, the identi ication of these ceRNAs will undoubtedly enhance our knowledge of how ncRNAs function, allowing us to better understand the pathogenesis and development of GC and ultimately facilitate the development of ncRNA-directed diagnostics and therapeutics against this deadly disease. 
